Madrigal Pharmaceuticals Inc. (NASDAQ:MDGL) is one of the high short interest stocks to buy right now. On November 21, H.C.
Since its launch, Rezdiffra has made steady commercial progress. In the third quarter, Madrigal's single approved product ...
The FDA has qualified the first AI-based tool that can be used in clinical trials involving patients with metabolic ...
MedPage Today brought together three hepatology experts for a virtual roundtable discussion on metabolic ...
Detailed price information for Galmed Pharmaceutica (GLMD-Q) from The Globe and Mail including charting and trades.
Madrigal Pharmaceuticals is relocating to a larger West Conshy headquarters as sales surge and its MASH treatment drives ...
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) has issued a new round of equity inducement awards to 24 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback